Trial
NCT03782402
Cannabinoids for Taxane Induced Peripheral Neuropathy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Chemotherapy-induced Peripheral Neuropathy
Intervention
Cannabinoids
Why stopped
Funding being sought
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-26